Display options
Cite
Dinh A, Berger A, Krane E. Analgesic Drug Development for Children: A History of Shortcomings … Until Now. J Pain Res. 2021;14:867-870doi: 10.2147/JPR.S291594.
Dinh, A., Berger, A., & Krane, E. (2021). Analgesic Drug Development for Children: A History of Shortcomings … Until Now. Journal of pain research, 14867-870. https://doi.org/10.2147/JPR.S291594
Dinh, Andrew, et al. "Analgesic Drug Development for Children: A History of Shortcomings … Until Now." Journal of pain research vol. 14 (2021): 867-870. doi: https://doi.org/10.2147/JPR.S291594
Dinh A, Berger A, Krane E. Analgesic Drug Development for Children: A History of Shortcomings … Until Now. J Pain Res. 2021 Mar 31;14:867-870. doi: 10.2147/JPR.S291594. eCollection 2021. PMID: 33833564; PMCID: PMC8020136.
Copy Download .nbib Format: NLM
Share it on

J Pain Res. 2021 Mar 31;14:867-870. doi: 10.2147/JPR.S291594. eCollection 2021.

Analgesic Drug Development for Children: A History of Shortcomings … Until Now.

Journal of pain research

Andrew Dinh, Ardin Berger, Elliot Krane

Affiliations

  1. Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  2. Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.

PMID: 33833564 PMCID: PMC8020136 DOI: 10.2147/JPR.S291594

[No abstract available.]

Conflict of interest statement

Dr. Elliot Krane has many years of experience consulting for governmental agencies as well as major pharmaceutical companies, including Gruenenthal, which is mentioned in this editorial. The authors r

References

  1. J Pain Res. 2019 May 31;12:1777-1790 - PubMed
  2. J Pain Res. 2019 Jun 28;12:1925-1936 - PubMed
  3. Lancet. 2020 Sep 26;396(10255):872-873 - PubMed
  4. J Pain Res. 2019 May 23;12:1649-1664 - PubMed
  5. J Pain Res. 2019 Nov 13;12:3099-3112 - PubMed
  6. J Pain Res. 2019 Oct 14;12:2835-2850 - PubMed

Publication Types